Biosynthetic gene cluster of carrimycin
AssigneeShenyang Fuyang Pharmaceutical Technology Co., Ltd.
InventorsYiguang Wang, Yang Jiang, Xiaofeng Zhao, Weiqing He, Jianlu Dai
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a biosynthetic gene cluster of carrimycin. The biosynthetic gene cluster comprises 44 gene open reading frames (orf), i.e., 5 orfs (orf10-14) encoding polyketide synthase, 9 orfs (orf1, 4-6, 15 and 36-39) related to polyketone synthesis extension unit and modification, 16 orfs (orf9, 16-22, 24, 26, 28, 29, 33-35 and 41) related to glycosyl synthesis, 6 orfs (orf7, 8, 30-32 and 40) related to glycosyl transfer, 2 orfs (orf3 and 25) related to resistance, 4 orfs (orf2, 23, 27 and 42) possibly related to regulation, a tsr resistance marker gene orf (orf43) and a 4″-mycaroseglucoside isovaleryl transferase gene orf (orf44).
Claims8
A polynucleotide comprising a carrimycin biosynthetic gene cluster, comprising 44 genes comprising:
- 1) five polyketide synthase genes, including orf10 residues 16215-10543 of SEQ ID NO:1, orf11 residues 21076-16328 of SEQ ID NO:1, orf12 residues 32511-21124 of SEQ ID NO:1, orf13 residues 38599-32585 of SEQ ID NO:1, orf14 residues 52259-38643 of SEQ ID NO:1;
- 2) nine genes related to polyketone synthesis extension unit and modification, including orf1 residues 1-645 of SEQ ID NO:1, orf4 residues 3614-4840 of SEQ ID NO:1, orf5 residues 4846-5511 of SEQ ID NO:1, orf 6 residues 7150-5801of SEQ ID NO:1, orf15 residues 53099-54310 of SEQ ID NO:1, orf36 residues 83164-82052 of SEQ ID NO:1, orf37 residues 84400-83279 of SEQ ID NO:1, orf38 residues 84713-84393 of SEQ ID NO:1, orf39 residues 85576-84710 of SEQ ID NO:1;
- 3) sixteen genes related to glycosyl synthesis, including orf9 residues 10543-9830 of SEQ ID NO:1, orf16 residues 54495-54845 of SEQ ID NO:1, orf17 residues 54842-56041 of SEQ ID NO:1, orf18 residues 56038-56946 of SEQ ID NO:1, orf19 residues 56930-57967 of SEQ ID NO:
- 1, orf20 residues 57937-60174 of SEQ ID NO:
- 1 orf21 residues 60836-61984 of SEQ ID NO:1, orf22 residues 62796-62077 of SEQ ID NO:1, orf24 residues 67379-66318 of SEQ ID NO:1, orf26 residues 69349-70650 of SEQ ID NO:1, orf28 residues 72422-73462 of SEQ ID NO:1, orf29 residues 74601-73561 of SEQ ID NO:1, orf33 residues 78783-79775 of SEQ ID NO:
- 1, orf34 residues 79772-80779 of SEQ ID NO:1, orf35 residues 82055-80823 of SEQ ID NO:1 and orf41 residues 87094-87702 of SEQ ID NO:1;
- 4) six genes related to glycosyl transfer, including orf7 residues 8444-7179 of SEQ ID NO:1, orf8 residues 9729-8482 of SEQ ID NO:1, orf30 residues 74913-76160 of SEQ ID NO:1, orf31 residues 76218-77486 of SEQ ID NO:1, orf32 residues 77606-78781of SEQ ID NO:1 and orf40 residues 85825-87042 of SEQ ID NO:1;
- 5) two genes related to resistance, including orf3 residues 3133-2285 of SEQ ID NO:1 and 25 residues 69004-67352 of SEQ ID NO:1;
- 6) four genes related to biosynthesis regulation, including orf2 residues 1810-1208 of SEQ ID NO:1, orf23 residues 63633-65645 of SEQ ID NO:1, orf27 residues 72156-70708 of SEQ ID NO:1 and orf42 residues 89315-88143 of SEQ ID NO:1;
- 7) two genes, including an exogenous genetic engineering marker gene orf43 residues 866-60 SEQ ID NO:2 and a mycarose 4″-O-hydroxyl isovaleryltransferase gene orf44 residues 2337-1174 of SEQ ID NO:2 linked to the orf43.
Dependencies are inferred from the claim text.